We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-4.67%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$268M
AUM Growth
-$87.1M
Cap. Flow
-$62.9M
Cap. Flow %
-23.5%
Top 10 Hldgs %
61.83%
Holding
30
New
2
Increased
4
Reduced
22
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.3M
2
AMGN icon
Amgen
AMGN
+$8.81M
3
ABT icon
Abbott
ABT
+$7.42M
4
CNC icon
Centene
CNC
+$1.66M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.63M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$12.1M
2
PFE icon
Pfizer
PFE
+$9.48M
3
CAH icon
Cardinal Health
CAH
+$7.69M
4
UHS icon
Universal Health Services
UHS
+$6.17M
5
GMED icon
Globus Medical
GMED
+$5.65M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$28.8M 10.77%
420,163
+154,544
+58% +$10.3M
PFE icon
2
Pfizer
PFE
$143B
$25M 9.36%
895,000
-344,165
-28% -$9.48M
BMY icon
3
Bristol-Myers Squibb
BMY
$124B
$22.2M 8.3%
535,000
+36,464
+7% +$1.63M
MDT icon
4
Medtronic
MDT
$106B
$20.8M 7.79%
264,890
-147,003
-36% -$12.1M
ELV icon
5
Elevance Health
ELV
$80.9B
$13.2M 4.91%
24,279
-10,018
-29% -$5.3M
CVS icon
6
CVS Health
CVS
$137B
$13M 4.85%
220,000
-88,004
-29% -$5.5M
INCY icon
7
Incyte
INCY
$23.4B
$12.3M 4.61%
203,376
-61,519
-23% -$3.48M
CAH icon
8
Cardinal Health
CAH
$53.5B
$10.5M 3.93%
107,098
-75,489
-41% -$7.69M
BIIB icon
9
Biogen
BIIB
$30.4B
$10.2M 3.81%
43,985
-15,713
-26% -$3.41M
AMGN icon
10
Amgen
AMGN
$198B
$9.37M 3.5%
+30,000
New +$8.81M
ZBH icon
11
Zimmer Biomet
ZBH
$17.6B
$9.23M 3.45%
85,000
-36,033
-30% -$4.25M
BAX icon
12
Baxter International
BAX
$11.7B
$8.7M 3.25%
260,000
-63,120
-20% -$2.33M
GEHC icon
13
GE HealthCare
GEHC
$28.7B
$8.1M 3.03%
104,000
-19,133
-16% -$1.56M
IONS icon
14
Ionis Pharmaceuticals
IONS
$8.99B
$8.1M 3.03%
170,000
-5,507
-3% -$226K
BRKR icon
15
Bruker
BRKR
$8.86B
$7.37M 2.75%
115,472
+2,697
+2% +$203K
ABT icon
16
Abbott
ABT
$175B
$7.27M 2.72%
+70,000
New +$7.42M
THC icon
17
Tenet Healthcare
THC
$16.8B
$7.03M 2.63%
52,861
-24,674
-32% -$2.97M
UHS icon
18
Universal Health Services
UHS
$9.15B
$6.47M 2.42%
35,000
-34,881
-50% -$6.17M
EW icon
19
Edwards Lifesciences
EW
$49.4B
$6.39M 2.39%
69,153
-37,713
-35% -$3.34M
AGIO icon
20
Agios Pharmaceuticals
AGIO
$2.36B
$5.25M 1.96%
121,844
-42,534
-26% -$1.54M
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$11.5B
$5.22M 1.95%
63,348
-18,068
-22% -$1.5M
ALKS icon
22
Alkermes
ALKS
$8.79B
$4.68M 1.75%
194,000
-58,319
-23% -$1.43M
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.15B
$4.6M 1.72%
16,829
-16,833
-50% -$4.9M
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$35.7B
$3.7M 1.38%
15,240
-12,343
-45% -$1.95M
QGEN icon
25
Qiagen
QGEN
$8.49B
$3.43M 1.28%
81,165
-19,333
-19% -$848K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2024 Portfolio in Review

As of Q2 2024, Sector Gamma AS held 30 positions worth $268M, down 25% from $355M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sector Gamma AS withdrew a net $62.9M in Q2 2024, closing 2 positions and reducing 22 holdings. Its most notable exit was Globus Medical, an estimated $5.65M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Amgen worth $9.37M.

  • Sector Gamma AS's largest Q2 2024 buy was Amgen: 30,000 shares worth $9.37M.
  • Sector Gamma AS added most to Gilead Sciences in Q2 2024, an estimated $10.3M increase.
  • Sector Gamma AS's biggest Q2 2024 reduction was Medtronic, cutting an estimated $12.1M.
  • Sector Gamma AS fully exited Globus Medical in Q2 2024, selling an estimated $5.65M.
  • Sector Gamma AS's ten largest holdings make up 62% of its $268M portfolio in Q2 2024.
  • Sector Gamma AS opened 2 new positions and closed 2 in Q2 2024.
  • Sector Gamma AS's portfolio value fell 25% quarter-over-quarter to $268M.

Based on Sector Gamma AS's 13F filing for Q2 2024, filed 9 Aug 2024.